High Resolution Retina Imaging
IHR
1 other identifier
observational
1,000
1 country
3
Brief Summary
To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2018
CompletedFirst Submitted
Initial submission to the registry
October 14, 2019
CompletedFirst Posted
Study publicly available on registry
October 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2024
CompletedOctober 16, 2019
October 1, 2019
5 years
October 14, 2019
October 14, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Evolution of retina diseases
Increase the clinical experience of using the rtx1 camera in various conditions with retinal impact
From date of inclusion until the date of last documented progression , assessed up to 5 years
Eligibility Criteria
Patients with pathologies affecting photoreceptors and the retinal vessels
You may qualify if:
- Persons over 12 years of age, of both sexes, presenting with retinal pathologies.
- Beneficiaries of the health insurance
You may not qualify if:
- Any abnormality preventing good quality OA imaging on both eyes
- Major under guardianship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hôpital Lariboisière
Paris, 75010, France
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, 75012, France
Hôpital Pitié-Salpétrière
Paris, 75013, France
Related Publications (1)
Paques M, Norberg N, Chaumette C, Sennlaub F, Rossi E, Borella Y, Grieve K. Long Term Time-Lapse Imaging of Geographic Atrophy: A Pilot Study. Front Med (Lausanne). 2022 Jun 22;9:868163. doi: 10.3389/fmed.2022.868163. eCollection 2022.
PMID: 35814763DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel PAQUES
Centre Hospitalier National d'Ophtalmologie des Quinze-Vints
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2019
First Posted
October 16, 2019
Study Start
January 17, 2018
Primary Completion
January 30, 2023
Study Completion
January 30, 2024
Last Updated
October 16, 2019
Record last verified: 2019-10